COST UTILITY ANALYSIS OF HPV VACCINATION WITH BIVALENT AS04 ADJUVANT VACCINE IN SLOVAKIA AND IMPACT OF VACCINE PROTECTION DURATION ON COST-EFFECTIVENESS ENDPOINTS

被引：0
|
作者：
Bielik, J. [1 ]
Foltan, V [2 ]
Psenkova, M. [3 ]
Hroncova, D. [4 ]
Marusakova, E. [5 ]
Sadovsky, O. [6 ]
机构：
[1] Fac Hlth, Trencin, Slovakia
[2] Comenius Univ, Bratislava, Slovakia
[3] Spol S Ro, Pharm In, Bratislava, Slovakia
[4] GSK, Noncommercial Educ Ctr, Bratislava, Slovakia
[5] GlaxoSmithKline Slovakia, Bratislava, Slovakia
[6] Natl Oncol Inst, Bratislava, Slovakia
来源：
VALUE IN HEALTH | 2010年 / 13卷 / 07期
关键词：
D O I：
10.1016/S1098-3015(11)73257-0
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A541 / A542
页数：2
相关论文
共 50 条
  • [41] Cost-effectiveness analysis of the introduction of rotavirus vaccine in Iran
    Javanbakht, Mehdi
    Moradi-Lakeh, Maziar
    Yaghoubi, Mohsen
    Esteghamati, Abdoulreza
    Ghanaie, Roxana Mansour
    Mahmoudi, Sussan
    Shamshiri, Ahmad-Reza
    Zahraei, Seyed Mohsen
    Baxter, Louise
    Shakerian, Sareh
    Chaudhri, Irtaza
    Fleming, Jessica A.
    Munier, Aline
    Baradaran, Hamid R.
    VACCINE, 2015, 33 : A192 - A200
  • [42] Dengue Dynamics and Vaccine Cost-Effectiveness Analysis in the Philippines
    Shim, Eunha
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2016, 95 (05): : 1137 - 1147
  • [43] Cost-effectiveness analysis of quadrivalent influenza vaccine in Spain
    Garcia, Amos
    Ortiz de Lejarazu, Raul
    Reina, Jordi
    Callejo, Daniel
    Cuervo, Jesus
    Morano Larragueta, Raul
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2016, 12 (09) : 2269 - 2277
  • [44] A cost-effectiveness analysis of Japanese encephalitis vaccine in Cambodia
    Touch, Sok
    Suraratdecha, Chutima
    Samnang, Chham
    Heng, Seng
    Gazley, Lauren
    Huch, Chea
    Sovann, Ly
    Chhay, Chab Seak
    Soeung, Sann Chan
    VACCINE, 2010, 28 (29) : 4593 - 4599
  • [45] COST-EFFECTIVENESS ANALYSIS OF THE INTRODUCTION OF THE VARICELLA VACCINE IN COLOMBIA
    De la Hoz, F.
    Alvis, N.
    Gamboa, O.
    Castaneda, C.
    Paternina, A.
    VALUE IN HEALTH, 2011, 14 (03) : A118 - A118
  • [46] Health impact and cost-effectiveness of implementing gender-neutral vaccination with the 9-valent HPV vaccine in Hong Kong
    Cheung, Tak Hong
    Cheng, Sally Shuk Yee
    Hsu, Danny
    Wing-Lei Wong, Queenie
    Pavelyev, Andrew
    Sukarom, Isaya
    Saxena, Kunal
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2023, 19 (02)
  • [47] The cost-effectiveness of influenza vaccination in elderly Australians: An exploratory analysis of the vaccine efficacy required
    Newall, Anthony T.
    Dehollain, Juan Pablo
    VACCINE, 2014, 32 (12) : 1323 - 1325
  • [48] Cost-effectiveness analysis of universal influenza vaccination with quadrivalent inactivated vaccine in the United States
    Clements, Karen M.
    Meier, Genevieve
    McGarry, Lisa J.
    Pruttivarasin, Narin
    Misurski, Derek A.
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2014, 10 (05) : 1171 - 1180
  • [49] EPIDEMIOLOGICAL AND COST-EFFECTIVENESS ANALYSIS OF THE CROSS PROTECTION DIFFERENCE BETWEEN THE BIVALENT AND THE QUADRIVALENT HPV VACCINES IN FRANCE
    Tehard, B.
    Demarteau, N.
    Fay, S.
    Essoh, A.
    Standaert, B.
    VALUE IN HEALTH, 2009, 12 (07) : A270 - A270
  • [50] Cost-effectiveness of 4CMenB Vaccination Against Gonorrhea: Importance of Dosing Schedule, Vaccine Sentiment, Targeting Strategy, and Duration of Protection
    Nikitin, Dariya
    Whittles, Lilith K.
    Imai-Eaton, Jeffrey W.
    White, Peter J.
    JOURNAL OF INFECTIOUS DISEASES, 2024, 231 (01): : 71 - 83
12345